Malcolm Salter
Directeur/Bestuurslid bij C4 THERAPEUTICS, INC.
Vermogen: 130 000 $ op 31-05-2024
Profiel
Malcolm S.
Salter's current jobs include being an Independent Director at C4 Therapeutics, Inc. since 2015, a Director at Raqia Therapeutics, Inc. since 2020, a Director at NextRNA Therapeutics, Inc. since 2021, and a Director at AI Proteins, Inc. since 2022.
He is also currently affiliated with Harvard Business School as a Principal.
Mr. Salter's former jobs include being the President of Mars & Co. Consulting, Inc. from 1986 to 2006.
He also served as a Trustee at Dana-Farber Cancer Institute, Inc. In terms of education, Mr. Salter attended Harvard University where he obtained undergraduate and doctorate degrees.
He also attended Harvard Business School and earned an MBA.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0.04% | 23-04-2024 | 26 000 ( 0.04% ) | 130 000 $ | 31-05-2024 |
Actieve functies van Malcolm Salter
| Bedrijven | Functie | Begin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-12-2015 |
| Harvard Business School | Corporate Officer/Principal | - |
| Raqia Therapeutics, Inc. | Directeur/Bestuurslid | 01-09-2020 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Directeur/Bestuurslid | 01-02-2021 |
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Directeur/Bestuurslid | 01-01-2022 |
Eerdere bekende functies van Malcolm Salter
| Bedrijven | Functie | Einde |
|---|---|---|
Mars & Co. Consulting, Inc.
 Mars & Co. Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Mars & Co. The private company is based in Greenwich, CT. Consulting, Inc. is a strategy consulting firm. | President | 01-01-2006 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Directeur/Bestuurslid | - |
Opleiding van Malcolm Salter
| Harvard University | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| C4 THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Mars & Co. Consulting, Inc.
Mars & Co. Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Mars & Co. The private company is based in Greenwich, CT. Consulting, Inc. is a strategy consulting firm. | Commercial Services |
| Raqia Therapeutics, Inc. | |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Health Technology |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Health Technology |
